did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780683302660

Principles and Practice of Psychopharmacotherapy

by ; ; ;
  • ISBN13:

    9780683302660

  • ISBN10:

    0683302663

  • Edition: 2nd
  • Format: Hardcover
  • Copyright: 1997-06-01
  • Publisher: Williams & Wilkins
  • View Upgraded Edition

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $105.00 Save up to $26.25
  • Buy Used
    $78.75
    Add to Cart Free Shipping Icon Free Shipping

    USUALLY SHIPS IN 2-4 BUSINESS DAYS

Supplemental Materials

What is included with this book?

Summary

Completely updated in its Third Edition, this text provides an evidence-based approach to the clinical use of today's psychotropic drugs. The book comprehensively summarizes the scientific and clinical research literature and offers treatment strategies that flow directly from scientific data. The first chapter sets forth key principles of psychopharmacotherapy, foremost of which is the thorough assessment of the patient's history that helps establish the appropriate role of drug therapy. Subsequent chapters discuss the major categories of psychiatric drugs, present strategies for their therapeutic use, and discuss meta-analyses of clinical and scientific studies. Concluding chapters address anxiety disorders and special populations. Each chapter has user-friendly features such as highlighted/italicized text, tables, bulleted lists, and diagrams.

Table of Contents

Foreword vii(4)
Preface to the Second Edition xi(2)
Preface to the First Edition xiii
1 General Principles
1(30)
Principles of Psychopharmacotherapy
2(6)
Role of Neuroscience
8(2)
Diagnostic Assessment
10(4)
Role of the Laboratory
14(17)
2 Assessment of Drug Efficacy and Relevant Clinical Issues
31(30)
Evaluation of Drug Study Designs
31(6)
Statistical Summarization of Drug Studies
37(8)
Patient Issues
45(7)
Drug Management
52(2)
Role of the Food and Drug Administration
54(4)
Cost of Treatment
58(3)
3 Pharmacokinetics
61(24)
General Principles
61(3)
Role of Pharmacokinetics
64(1)
Alterations in Pharmacokinetics
65(4)
The Four Primary Pharmacokinetic Phases
69(8)
Therapeutic Drug Monitoring
77(8)
4 Indications for Antipsychotics
85(12)
Schizophrenia
85(5)
Other Psychotic Disorders
90(4)
Nonpsychotic Disorders
94(3)
5 Treatment With Antipsychotics
97(122)
History
97(3)
Mechanism of Action
100(7)
Effects on Cognition and Behavior
107(3)
Management of Acute Psychosis
110(30)
Maintenance/Prophylaxis
140(15)
Long-Acting Antipsychotics
155(5)
Pharmacokinetics/Plasma Levels
160(12)
Alternative Treatment Strategies
172(10)
Role of Psychosocial Therapies
182(6)
Adverse Effects
188(31)
6 Indications for Antidepressant Therapy
219(24)
Depressive Disorders
219(17)
Suicide
236(6)
Other Costs of Major Depression
242(1)
7 Treatment With Antidepressants
243(114)
History
243(2)
Mechanism of Action
245(11)
Treatment Planning
256(4)
Management of an Acute Depressive Episode
260(35)
Maintenance/Prophylaxis
295(7)
Pharmacokinetics
302(4)
Therapeutic Drug Monitoring
306(9)
Alternative Treatment Strategies
315(4)
Role of Psychosocial Therapies
319(2)
Adverse Effects
321(36)
8 Treatment With Electroconvulsive Therapy and Other Somatic Therapies
357(46)
Electroconvulsive Therapy
357(25)
Experimental Somatic Therapies
382(7)
9 Indications for Mood Stabilizers
389(1)
Bipolar Disorder
389(14)
10 Treatment With Mood Stabilizers
403(72)
History
403(2)
Mechanism of Action
405(7)
Management of an Acute Manic Episode
412(16)
Maintenance/Prophylaxis
428(13)
Alternative Treatment Strategies
441(20)
Adverse Effects of Lithium and Valproate
461(9)
Adverse Effects of Other Drugs
470(5)
11 Indications for Antianxiety and Sedative-Hypnotic Agents
475(8)
Generalized Anxiety Disorder
475(2)
Phobic Disorders
477(1)
Psychological Factors Affecting Medical Condition
478(1)
Sleep Disorders
479(4)
12 Treatment With Antianxiety and Sedative-Hypnotic Agents
483(54)
History
483(2)
Mechanism of Action
485(2)
Treatment of Generalized Anxiety Disorder
487(8)
Treatment of Phobic Disorders
495(2)
Treatment of Sleep Disorders
497(12)
Pharmacokinetics
509(3)
Adverse Effects of Anxiolytics
512(13)
Adverse Effects of Sedative-Hypnotics
525(12)
13 Assessment and Treatment of Other Disorders
537(32)
Panic Disorder
537(15)
Obsessive-Compulsive Disorder
552(13)
Trichotillomania
565(1)
Posttraumatic Stress Disorder
565(4)
14 Assessment and Treatment of Special Populations
569(82)
The Pregnant Patient
569(4)
The Child and the Adolescent Patient
573(21)
The Personality-Disordered Patient
594(9)
The Elderly Patient
603(15)
The Dying Patient
618(5)
The Alcoholic Patient
623(12)
The Human Immunodeficiency Virus-Infected Patient
635(6)
The Eating-Disordered Patient
641(6)
Conclusion
647(4)
Appendices 651(24)
Index 675

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program